drugset / Trial / NCT01128595

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

NCT01128595

Phase 2 Completed 27 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

We propose to use an inhaled allergen challenge model to explore the individual contributions of the components of a novel long-acting beta agonist/ inhaled corticosteroid combination product and its components on protection from allergic triggers in asthma

Timeline

Start
2010-05
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified Inhaled
Comparator GW642444M Small molecule Inhaled

Indications